Introduction Introduction
This quality standard covers the recognition, assessment and management of coeliac disease in children, young people and adults. For more information, see the coeliac disease topic overview.
NICE quality standards focus on aspects of health and social care that are commissioned locally.
Areas of national policy, such as food labelling, are therefore not covered by this quality standard.
Why this quality standard is needed
Coeliac disease is an autoimmune condition associated with chronic inflammation of the small intestine, which can lead to malabsorption of nutrients. It is a common condition and population screening studies suggest that in the UK, 1 in 100 people are affected. The complications of coeliac disease (which may or may not be present at diagnosis) can include osteoporosis, ulcerative jejunitis, malignancy (intestinal lymphoma), functional hyposplenism, vitamin D deficiency and iron deficiency.
Coeliac disease is underdiagnosed, particularly when people present in primary care and other non-specialist settings. Delayed diagnosis is a concern because of the possible long-term complications of undiagnosed coeliac disease. People with conditions such as type 1 diabetes, autoimmune thyroid disease, Down's syndrome and Turner syndrome are at a higher risk than the general population of having coeliac disease. First-degree relatives of a person with coeliac disease also have an increased likelihood of having coeliac disease.
The main treatment for coeliac disease is a lifelong gluten-free diet. Most people report a rapid clinical improvement after starting a gluten-free diet. Specific education and information, such as advice on alternative foods to maintain a healthy and varied diet, may increase the likelihood of adherence and a positive prognosis.
Some people do not report symptomatic improvement after starting treatment, and some will still have persisting symptoms after 6 to 12 months. Follow-up care for people diagnosed with coeliac disease varies widely in the UK and therefore the needs of people whose symptoms do not improve
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may not be addressed.
The quality standard is expected to contribute to improvements in the following outcomes: diagnosis of coeliac disease growth in children and young people health-related quality of life incidence of osteoporosis incidence of intestinal lymphoma incidence of vitamin D deficiency incidence of iron deficiency.
How this quality standard supports delivery of outcome frameworks
NICE quality standards are a concise set of prioritised statements designed to drive measurable improvements in the 3 dimensions of quality -patient safety, patient experience and clinical effectiveness -for a particular area of health or care. They are derived from high-quality guidance, such as that from NICE or other sources accredited by NICE. This quality standard, in conjunction with the guidance on which it is based, should contribute to the improvements outlined in the following 2 outcomes frameworks published by the Department of Health:
NHS outcomes framework Public health outcomes framework for England 2016-19. Tables 1 and 2 show the outcomes, overarching indicators and improvement areas from the frameworks that the quality standard could contribute to achieving.
T NICE has developed guidance and an associated quality standard on patient experience in adult NHS services (see the NICE pathway on patient experience in adult NHS services), which should be considered alongside this quality standard. They specify that people receiving care should be treated with dignity, have opportunities to discuss their preferences, and be supported to understand their options and make fully informed decisions. They also cover the provision of information to people using services. Quality statements on these aspects of patient experience are not usually included in topic-specific quality standards. However, recommendations in the development sources for quality standards that affect people's experience of using services and are specific to the topic are considered during quality statement development.
Coordinated services
The quality standard for coeliac disease specifies that services should be commissioned from and coordinated across all relevant agencies encompassing the whole coeliac disease care pathway. A person-centred, integrated approach to providing services is fundamental to delivering highquality care to people with coeliac disease. 
Rationale
Coeliac disease is currently underdiagnosed. If coeliac disease is not recognised, there is a risk of complications, unnecessary investigations and a poor quality of life. Offering serological testing when there is a new diagnosis for a condition that increases the risk of having coeliac disease or at presentation of symptoms of coeliac disease will improve detection and diagnosis, thereby enabling people to begin treatment.
Quality measures
Structure Structure
Evidence of local arrangements to undertake serological testing for people identified with increased risk or symptoms of coeliac disease.
Data sour
Data source: ce: Local data collection.
Process Process a) Proportion of people at increased risk of coeliac disease who receive a serological test for coeliac disease.
Numerator -the number in the denominator who receive a serological test for coeliac disease.
Denominator -the number of people at increased risk of coeliac disease (people with type 1 diabetes or autoimmune thyroid disease at diagnosis, and first-degree relatives of people newly diagnosed with coeliac disease). Numerator -the number in the denominator who receive a serological test for coeliac disease.
Denominator -the number of people who have symptoms of coeliac disease.
Data source: ce: Local data collection. To aid practicality of measurement, service providers and commissioners could focus on people presenting with symptoms of irritable bowel syndrome.
Outcome Outcome
Diagnosed prevalence of coeliac disease.
Data source: ce:Local data collection.
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (for example general practices, community healthcare providers and secondary care) ensure that they take a case-finding approach to identifying coeliac disease by offering a serological test to people at increased risk or with symptoms of coeliac disease. Providers should ensure that tests for coeliac disease are only carried out when a gluten-containing diet has been followed for at least 6 weeks.
Healthcare professionals
Healthcare professionals (such as GPs and consultants) offer a serological test for coeliac disease to people at increased risk or with symptoms of coeliac disease, and ensure that people have been following a gluten-containing diet for at least 6 weeks before the test.
Commissioners Commissioners (such as clinical commissioning groups and NHS England) commission services that take a case-finding approach to identifying coeliac disease by offering a serological test to people at increased risk or with symptoms of coeliac disease; and ensure that they commission a pathology service that has access to the serological tests for coeliac disease. 
What the quality statement means for patients and carers

Quality statement
People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten-containing diet until diagnosis is confirmed.
Rationale
As a positive serological result for coeliac disease is not sufficient to confirm diagnosis, people
should be referred to a specialist for assessment and further investigation. Confirming diagnosis will ensure that people with coeliac disease can get support to help them manage their condition.
Quality measures
Structure Structure a) Evidence of local arrangements to ensure that people with a positive serological test for coeliac disease are referred to a specialist. Numerator -the number in the denominator who are referred to a specialist.
Data sour
Denominator -the number of people with a positive serological test for coeliac disease.
b) Proportion of people referred to a specialist following a positive serological test for coeliac disease who are advised to continue with a gluten-containing diet until diagnosis is confirmed.
Numerator -the number in the denominator who are advised to continue with a gluten-containing diet until diagnosis is confirmed.
Denominator -the number of people referred to a specialist following a positive serological test for coeliac disease. 
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (for example general practices, community healthcare providers and secondary care) ensure that processes are in place for people with a positive serological test for coeliac disease to be referred to a specialist and advised to continue with a gluten-containing diet until diagnosis is confirmed.
Healthcare professionals Healthcare professionals (such as GPs and consultants) refer people with a positive serological test for coeliac disease to a specialist and advise them to continue with a gluten-containing diet until diagnosis is confirmed.
Commissioners Commissioners (such as clinical commissioning groups and NHS England) commission services that refer people with a positive serological test for coeliac disease to a specialist and advise them to continue with a gluten-containing diet until diagnosis is confirmed. Commissioners also ensure that an effective specialist service for people with coeliac disease has capacity to meet expected demand.
What the quality statement means for patients and carers
P People who ha eople who hav ve had a blood test that shows the e had a blood test that shows they might ha y might hav ve coeliac disease e coeliac disease should be referred to a specialist to have more tests to confirm whether or not they have coeliac disease. They should carry on eating foods containing gluten until they find out whether or not they have coeliac disease. Gluten-containing diet Gluten-containing diet
Source guidance
People who are following a normal diet (containing gluten) should be advised to eat gluten in more than 1 meal every day for at least 6 weeks before testing for coeliac disease.
[Coeliac disease (NICE guideline NG20) recommendation 1.
1.4]
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Quality statement 3: Endoscopic intestinal biopsy Quality statement 3: Endoscopic intestinal biopsy
Quality statement
People referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.
Rationale
A long wait for an endoscopic intestinal biopsy can mean that some people will start a gluten-free diet to relieve symptoms and will therefore not be able to complete the diagnosis process. Limiting the time that people need to continue with a gluten-containing diet to 6 weeks or less will encourage more people to complete the diagnosis process and enable them to get the support they need.
Quality measures
Structure Structure
Evidence of local processes to ensure that people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.
Data sour
Process Process a) Proportion of people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease who have it within 6 weeks of referral.
Numerator -the number in the denominator who have an endoscopic intestinal biopsy within 6 weeks of referral.
Denominator -the number of people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease.
b) Proportion of people with a positive serological test for coeliac disease who complete the diagnosis process.
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Numerator -the number in the denominator who complete the diagnosis process.
Denominator -the number of people with a positive serological test for coeliac disease. 
Data sour
What the quality statement means for service providers, healthcare professionals, and commissioners
Service pro Service providers viders (secondary care) ensure that people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.
Healthcare professionals
Healthcare professionals (such as gastroenterologists and paediatricians) carry out an endoscopic intestinal biopsy to diagnose coeliac disease within 6 weeks of referral.
Commissioners Commissioners (clinical commissioning groups) commission services with sufficient capacity to carry out an endoscopic intestinal biopsy to diagnose coeliac disease within 6 weeks of referral to a specialist.
What the quality statement means for patients and carers
P People who ha eople who hav ve had a blood test that shows the e had a blood test that shows they might ha y might hav ve coeliac disease e coeliac disease may need a biopsy to confirm the diagnosis. The biopsy should be carried out within 6 weeks of the referral. They will need to carry on eating foods containing gluten until they have had the biopsy.
Source guidance
Coeliac disease: recognition, assessment and management (2015) NICE guideline NG20, recommendations 1.3.1 and 1.3.2
The timeframe is informed by the Joint Advisory Group on GI Endoscopy guidance for nonurgent referrals.
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Quality statement 4: Advice about a gluten-free diet Quality statement 4: Advice about a gluten-free diet
Quality statement
People newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.
Rationale
A gluten-free diet is the main treatment for coeliac disease. If people with coeliac disease do not follow a gluten-free diet they may experience continuing ill health and be at risk of serious longterm complications. Personalised information and advice about a gluten-free diet from a healthcare professional with specialist knowledge of coeliac disease will help people to understand and self-manage their condition.
Quality measures
Structure Structure
Evidence of local arrangements to ensure that people newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.
Data sour
Process Process
Proportion of people newly diagnosed with coeliac disease who discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.
Numerator -the number in the denominator who discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.
Denominator -the number of people newly diagnosed with coeliac disease. 
Data sour
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (for example general practices, community healthcare providers and secondary care) ensure that processes are in place for people newly diagnosed with coeliac disease to discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease, such as a dietitian.
Healthcare professionals
Healthcare professionals (such as consultants or GPs) ensure that people newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease, such as a dietitian.
Commissioners Commissioners (such as clinical commissioning groups and NHS England) commission services that ensure that people newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease, such as a dietitian, and that services have sufficient capacity to meet demand.
What the quality statement means for patients and carers
P People who ha eople who hav ve coeliac disease and their carers e coeliac disease and their carers (if appropriate) discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease, such as a dietitian.
Source guidance
Coeliac disease: recognition, assessment and management (2015) NICE guideline NG20, [Coeliac disease (NICE guideline NG20) recommendation 1.6.3 and expert opinion]
Equality and diversity considerations
Gluten-free products are more expensive and are usually only available from larger retailers, making access more difficult for people on low incomes or with limited mobility. As coeliac disease can affect more than one member of a family it can also be an additional burden on the family budget. To address this, healthcare professionals should highlight if gluten-free food products are available on prescription to help people to maintain a gluten-free diet.
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Quality statement
People with coeliac disease are offered an annual review.
Rationale
An annual review should be offered to people with coeliac disease so that adherence to a glutenfree diet and symptoms can be reviewed, information and advice about the condition and diet can be refreshed, and any further support needs can be identified. Annual reviews for children with coeliac disease also allow any impact on development to be assessed. Annual reviews provide the opportunity to identify people with refractory coeliac disease that does not improve with a gluten-free diet and to monitor any emerging long-term complications of coeliac disease.
Quality measures
Evidence of local arrangements to ensure that people with coeliac disease are offered an annual review.
Data sour
Process Process
Proportion of people diagnosed with coeliac disease for more than 12 months who received an annual review in the previous 12 months.
Numerator -the number in the denominator who received an annual review in the previous 12 months.
Denominator -the number of people diagnosed with coeliac disease for more than 12 months.
Data sour
Outcome Outcome a) Health-related quality of life for people with coeliac disease. ensure that people with coeliac disease, including those discharged from secondary care, are offered an annual review and are given information about why they may need a review to encourage attendance. Service providers should consider innovative approaches to undertake reviews, including using technology to improve access to specialist advice.
Healthcare professionals Healthcare professionals (for example, dietitians, consultants, and GPs) offer an annual review to people with coeliac disease, including those discharged from secondary care, and encourage them to attend by giving them information about why they may need a review.
Commissioners Commissioners (for example, clinical commissioning groups and NHS England) ensure that they commission services that offer an annual review to people with coeliac disease, including those discharged from secondary care. Commissioners encourage service providers to use innovative approaches to undertake reviews, including using technology to improve access to specialist advice.
What the quality statement means for patients and carers
P People who ha eople who hav ve coeliac disease e coeliac disease have a check-up once a year to check their symptoms and diet, and to find out whether they need further advice or assessment.
Source guidance
Coeliac disease: recognition, assessment and management (2015) NICE guideline NG20, The quality measures accompanying the quality statements aim to improve the structure, process and outcomes of care in areas identified as needing quality improvement. They are not a new set of targets or mandatory indicators for performance management.
We have indicated if current national indicators exist that could be used to measure the quality statements. If there is no national indicator that could be used to measure a quality statement, the quality measure should form the basis for audit criteria developed and used locally.
See how to use quality standards for more information, including advice on using quality measures.
Levels of achievement
Expected levels of achievement for quality measures are not specified. Quality standards are intended to drive up the quality of care, and so achievement levels of 100% should be aspired to (or 0% if the quality statement states that something should not be done). However, NICE recognises that this may not always be appropriate in practice, taking account of safety, choice and professional judgement, and therefore desired levels of achievement should be defined locally.
NICE's quality standard service improvement template helps providers to make an initial assessment of their service compared with a selection of quality statements. It includes assessing current practice, recording an action plan and monitoring quality improvement. This tool is updated monthly to include new quality standards.
Using other national guidance and policy documents
Other national guidance and current policy documents have been referenced during the development of this quality standard. It is important that the quality standard is considered alongside the documents listed in development sources.
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Further explanation of the methodology used can be found in the quality standards process guide.
Evidence sources
The documents below contain recommendations from NICE guidance or other NICE-accredited recommendations that were used by the quality standards advisory committee to develop the quality standard statements and measures.
Coeliac disease: recognition, assessment and management (2015) NICE guideline NG20
Irritable bowel syndrome in adults: diagnosis and management (2008) NICE guideline CG61
Policy context
It is important that the quality standard is considered alongside current policy documents, including:
The 
Endorsing organisation
This quality standard has been endorsed by NHS England, as required by the Health and Social Care Act (2012)
Supporting organisations
Many organisations share NICE's commitment to quality improvement using evidence-based guidance. The following supporting organisations have recognised the benefit of the quality standard in improving care for patients, carers, service users and members of the public. They have agreed to work with NICE to ensure that those commissioning or providing services are made aware of and encouraged to use the quality standard.
• 
